{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:54:46Z","timestamp":1793357686811,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vph.2023.107255","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T23:38:45Z","timestamp":1703806725000},"page":"107255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["Inflammation and the pathogenesis of atherosclerosis"],"prefix":"10.1016","volume":"154","author":[{"given":"Peter","family":"Libby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2023.107255_bb0005","first-page":"5","article-title":"Atherosclerosis","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.vph.2023.107255_bb0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCRESAHA.120.316903","article-title":"Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas","volume":"127","author":"Zernecke","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2023.107255_bb0015","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"369","author":"Libby","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2023.107255_bb0020","first-page":"2984","article-title":"Requiem for the \u2018vulnerable plaque\u2019","volume":"36","author":"Libby","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2023.107255_bb0025","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehx786","article-title":"Plaque erosion: a new in vivo diagnosis and a potential major shift in the management of patients with acute coronary syndromes","volume":"39","author":"Partida","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2023.107255_bb0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrcardio.2016.166","article-title":"Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease","volume":"14","author":"Pasterkamp","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.vph.2023.107255_bb0035","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature."},{"key":"10.1016\/j.vph.2023.107255_bb0040","doi-asserted-by":"crossref","DOI":"10.1097\/MOL.0000000000000440","article-title":"Mechanisms of erosion of atherosclerotic plaques","author":"Quillard","year":"2017","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.vph.2023.107255_bb0045","first-page":"ehad379","article-title":"Toll-like receptor 2, hyaluronan, and neutrophils play a key role in plaque erosion: the OPTICO\u2013ACS study","author":"Meteva","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2023.107255_bb0050","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jacc.2015.12.048","article-title":"Leukocytes link local and systemic inflammation in ischemic cardiovascular disease","volume":"67","author":"Libby","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2023.107255_bb0055","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCRESAHA.120.315895","article-title":"Hematopoiesis and cardiovascular disease","volume":"126","author":"Poller","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2023.107255_bb0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s44161-021-00002-8","article-title":"Bone marrow endothelial dysfunction promotes myeloid cell expansion in cardiovascular disease","volume":"1","author":"Rohde","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.vph.2023.107255_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41569-019-0247-5","article-title":"Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease","volume":"17","author":"Jaiswal","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.vph.2023.107255_bb0070","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jacc.2023.03.401","article-title":"Clonal hematopoiesis of indeterminate potential predicts adverse outcomes in patients with atherosclerotic cardiovascular disease","volume":"81","author":"Gumuser Esra","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2023.107255_bb0075","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","article-title":"TET2-driven clonal hematopoiesis and response to Canakinumab","volume":"7","author":"Svensson","year":"2022","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.vph.2023.107255_bb0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1126\/science.abn3100","article-title":"Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality","volume":"377","author":"Sano","year":"2022","journal-title":"Science."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123001155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123001155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T07:03:04Z","timestamp":1724655784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189123001155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":16,"alternative-id":["S1537189123001155"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2023.107255","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation and the pathogenesis of atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2023.107255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107255"}}